MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness - 04/02/21
, Jeffrey E. Gold c, MaryJane A. Huenergardt, MBA d, Ronit B.A. Katz, MD, FACPM e, Susanne E. Strand, MPhil f, Joe Bolanos, MD f, Christopher J. Wheeler, PhD h, i, George Perry, PhD j, Carr J. Smith, PhD k, Lawrence Steinman, MD l, Mike Y. Chen, MD, PhD m, Jeffrey C. Wang, MD n, Clinton B. Ashford, MD o, Walton T. Roth, MD b, Jauhtai Joseph Cheng, MD p, q, Steven Chao, MD p, q, Jennifer Jennings, MD p, Daniel Sipple, DO, FABPMR, DABPM h, Vicky Yamamoto, PhD r, Babak Kateb, MD h, David L. Earnest, MD s| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: Each author was involved in substantial discussions about the possible relationship of COVID-19 to MMR vaccination, had access to the data, and either provided specific suggestions about the relationship, assisted with reviewing the literature, or participated significantly in the drafting and editing of the manuscript. All authors have carefully reviewed the manuscript and strongly endorse the recommendations. |
Vol 134 - N° 2
P. 153-155 - février 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
